Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) that specifically targets the epidermal growth factor receptor (EGFR). This reagent exhibits potent antitumor activity and is valuable for research applications involving glioma, head and neck squamous cell carcinoma, non-small cell lung cancer, epidermoid carcinoma of the skin, and squamous cell carcinoma of the tongue. Its mechanism of action combines selective targeting of EGFR with cytotoxic delivery, making it a significant tool in cancer research and therapeutic studies.
Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) that specifically targets the epidermal growth factor receptor (EGFR). This reagent exhibits potent antitumor activity and is valuable for research applications involving glioma, head and neck squamous cell carcinoma, non-small cell lung cancer, epidermoid carcinoma of the skin, and squamous cell carcinoma of the tongue. Its mechanism of action combines selective targeting of EGFR with cytotoxic delivery, making it a significant tool in cancer research and therapeutic studies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
